{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:38:57Z","timestamp":1788046737445,"version":"build-2784847793"},"reference-count":47,"publisher":"Elsevier BV","issue":"29-30","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.vaccine.2008.04.079","type":"journal-article","created":{"date-parts":[[2008,5,21]],"date-time":"2008-05-21T19:11:16Z","timestamp":1211397076000},"page":"3587-3593","source":"Crossref","is-referenced-by-count":24,"title":["Saccharide\/protein conjugate vaccines for Bordetella species: Preparation of saccharide, development of new conjugation procedures, and physico-chemical and immunological characterization of the conjugates"],"prefix":"10.1016","volume":"26","author":[{"given":"Joanna","family":"Kubler-Kielb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Vinogradov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Ben-Menachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vince","family":"Pozsgay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Schneerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.04.079_bib1","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/gb-2006-7-9-r81","article-title":"Genomic features of Bordetella parapertussis clades with distinct host species specificity","volume":"7","author":"Brinig","year":"2006","journal-title":"Genome Biol"},{"key":"10.1016\/j.vaccine.2008.04.079_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(94)90485-5","article-title":"Parapertussis infection followed by pertussis infection","volume":"344","author":"Taranger","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.04.079_bib3","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1128\/JCM.31.7.1838-1844.1993","article-title":"Fimbriae and determination of host species specificity of Bordetella bronchiseptica","volume":"31","author":"Burns","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.04.079_bib4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/MMBR.44.4.722-738.1980","article-title":"Biology of Bordetella bronchiseptica","volume":"44","author":"Goodnow","year":"1980","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.04.079_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0034-5288(18)33007-8","article-title":"Vaccination against Bordetella bronchiseptica infection in dogs using a heat-killed bacterial vaccine","volume":"25","author":"McCandlish","year":"1978","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2008.04.079_bib6","first-page":"191","article-title":"Efficacy of commercial vaccines for protecting guinea pigs against Bordetella bronchiseptica pneumonia","volume":"37","author":"Matherne","year":"1987","journal-title":"Lab Anim Sci"},{"key":"10.1016\/j.vaccine.2008.04.079_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2460\/javma.2002.220.43","article-title":"Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs","volume":"220","author":"Ellis","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2008.04.079_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/IAI.55.3.497-501.1987","article-title":"Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis","volume":"55","author":"Marchitto","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.04.079_bib9","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1128\/jb.169.6.2847-2853.1987","article-title":"Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes","volume":"169","author":"Arico","year":"1987","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2008.04.079_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(96)06255-1","article-title":"Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults","volume":"349","author":"Cohen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.04.079_bib11","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/IAI.66.7.3095-3099.1998","article-title":"Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers","volume":"66","author":"Gupta","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.04.079_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/clinids\/15.2.346","article-title":"Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides","volume":"15","author":"Robbins","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.079_bib13","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1128\/IAI.60.12.5316-5318.1992","article-title":"A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis","volume":"60","author":"Mountzouros","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.04.079_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1179\/096805101101532567","article-title":"Structural variability and originality of the Bordetella endotoxins","volume":"7","author":"Caroff","year":"2001","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.vaccine.2008.04.079_bib15","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1046\/j.1432-1327.2000.01512.x","article-title":"The structure of the carbohydrate backbone of the lipopolysaccharides from Bordetella hinzii and Bordetella bronchiseptica","volume":"267","author":"Vinogradov","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2008.04.079_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0378-1097(92)90348-R","article-title":"Characterization of the common antigenic lipopolysaccharide O-chains produced by Bordetella bronchiseptica and Bordetella parapertussis","volume":"97","author":"Di Fabio","year":"1992","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2008.04.079_bib17","doi-asserted-by":"crossref","first-page":"18135","DOI":"10.1074\/jbc.M513904200","article-title":"Complete structures of Bordetella bronchiseptica and Bordetella parapertussis lipopolysaccharides","volume":"281","author":"Preston","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2008.04.079_bib18","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1046\/j.1432-1327.2000.01835.x","article-title":"The structure of the nonreducing terminal groups in the O-specific polysaccharides from two strains of Bordetella bronchiseptica","volume":"276","author":"Vinogradov","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2008.04.079_bib19","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1074\/jbc.273.5.2777","article-title":"On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba","volume":"273","author":"Wang","year":"1998","journal-title":"Biol Chem"},{"key":"10.1016\/j.vaccine.2008.04.079_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1099\/00221287-63-2-211","article-title":"A simple chemically defined medium for the production of phase I Bordetella pertussis","volume":"63","author":"Stainer","year":"1970","journal-title":"J Gen Microbiol"},{"key":"10.1016\/j.vaccine.2008.04.079_bib21","first-page":"83","article-title":"Extraction with phenol-water and further application of the procedure","volume":"5","author":"Westphal","year":"1965","journal-title":"Methods Carbohydr Chem"},{"key":"10.1016\/j.vaccine.2008.04.079_bib22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1099\/00221287-142-4-971","article-title":"Epitopes of Bordetella pertussis lipopolysaccharides as potential markers for typing of isolates with monoclonal antibodies","volume":"142","author":"Le Blay","year":"1996","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2008.04.079_bib23","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1021\/jo050934b","article-title":"A new method for conjugation of carbohydrates to proteins using an aminooxy-thiol heterobifunctional linker","volume":"70","author":"Kubler-Kielb","year":"2005","journal-title":"J Org Chem"},{"key":"10.1016\/j.vaccine.2008.04.079_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1084\/jem.152.2.361","article-title":"Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates","volume":"152","author":"Schneerson","year":"1980","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.04.079_bib25","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1128\/IAI.59.12.4450-4458.1991","article-title":"Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid","volume":"59","author":"Chu","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.04.079_bib26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2008.04.079_bib27","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/IAI.61.9.3678-3687.1993","article-title":"Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids","volume":"61","author":"Taylor","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.04.079_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-1759(94)90355-7","article-title":"Enhanced ELISA sensitivity using TCA for efficient coating of biologically active lipopolysaccharides or lipid A to the solid phase","volume":"176","author":"Hardy","year":"1994","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2008.04.079_bib29","unstructured":"Plikaytis BD, Carlone GM. Program ELISA for Windows user's manual. Centers for Disease Control, Atlanta, GA, Version 2; 2005."},{"key":"10.1016\/j.vaccine.2008.04.079_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0008-6215(02)00395-6","article-title":"Conjugation of meningococcal lipooligosaccharides through their lipid A terminus conserves their inner epitopes and results in conjugate vaccines having improved immunological properties","volume":"338","author":"Mieszala","year":"2003","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.vaccine.2008.04.079_bib31","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1016\/j.vaccine.2005.06.011","article-title":"Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits","volume":"23","author":"Cox","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.079_bib32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0003-9861(77)90261-2","article-title":"Proteins containing reductively aminated disaccharides. Synthesis and chemical characterization","volume":"181","author":"Schwartz","year":"1977","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.vaccine.2008.04.079_bib33","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/IAI.73.11.7381-7389.2005","article-title":"Epitope of the vaccine-type Bordetella pertussis strain 186 lipooligosaccharide and antiendotoxin activity of antibodies directed against the terminal pentasaccharide-tetanus toxoid conjugate","volume":"73","author":"Niedziela","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.04.079_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/09680519020080040601","article-title":"A novel strategy for the synthesis of neoglycoconjugates from deacylated deep rough lipopolysaccharides","volume":"8","author":"Muller-Loennies","year":"2002","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.vaccine.2008.04.079_bib35","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/IAI.00315-06","article-title":"Additional conjugation methods and immunogenicity of B. anthracis poly-\u03b3-d-glutamic acid\u2013proteins conjugates","volume":"74","author":"Kubler-Kielb","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.04.079_bib36","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1073\/pnas.1633512100","article-title":"Poly-\u03b3-d-glutamic acid protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine","volume":"100","author":"Schneerson","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.04.079_bib37","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1073\/pnas.96.9.5194","article-title":"Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1","volume":"96","author":"Pozsgay","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2008.04.079_bib38","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1128\/IAI.70.9.5107-5114.2002","article-title":"Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197","volume":"70","author":"Mawas","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.04.079_bib39","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/IAI.66.6.2441-2446.1998","article-title":"Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes","volume":"66","author":"Laferriere","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.04.079_bib40","first-page":"48","article-title":"Glycoconjugates of bacterial carbohydrate antigens. A survey and consideration of design and preparation factors","volume":"10","author":"Dick","year":"1989","journal-title":"Contrib Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2008.04.079_bib41","series-title":"Frontiers in Modern Carbohydrate Synthesis, ACS Symposium Series, vol. 960","first-page":"238","article-title":"Synthesis of carbohydrate antigens related to Shigella dysenteriae type 1 and their protein conjugates","author":"Pozsgay","year":"2006"},{"key":"10.1016\/j.vaccine.2008.04.079_bib42","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.vaccine.2005.08.096","article-title":"Versatile and efficient synthesis of protein-polysaccharide conjugate vaccines using aminooxy reagents and oxime chemistry","volume":"24","author":"Lees","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.079_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10719-007-9045-0","article-title":"Pathogen specific carbohydrate antigen microarrays: a chip for detection of Salmonella O-antigen specific antibodies","volume":"25","author":"Blixt","year":"2008","journal-title":"Glycoconj J"},{"key":"10.1016\/j.vaccine.2008.04.079_bib44","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1432-1033.1994.1029b.x","article-title":"Isolation and structural analysis of oligosaccharide phosphates containing the complete carbohydrate chain of the lipopolysaccharide from Vibrio cholerae strain H11 (non-O1)","volume":"225","author":"Bock","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2008.04.079_bib45","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/S0021-9258(19)45117-X","article-title":"Xanthomonas sinensis cell wall lipopolysaccharide","volume":"24","author":"Volk","year":"1972","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2008.04.079_bib46","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1039\/P19910000509","article-title":"Phosphorylated sugars. Part 27. Synthesis and reactions, in acid medium, of 5-O-substituted methyl 3-deoxy-\u03b1-d-manno-oct-2-ulopyranosidonic acid 4-phosphates","author":"Auzanneau","year":"1991","journal-title":"J Chem Soc Perkin Trans I"},{"key":"10.1016\/j.vaccine.2008.04.079_bib47","first-page":"1161","article-title":"Nasal and tracheal resistance of swine against reinfection by Bordetella bronchiseptica","volume":"30","author":"Harris","year":"1969","journal-title":"Am J Vet Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T01:33:52Z","timestamp":1631324032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08005550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":47,"journal-issue":{"issue":"29-30","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0264410X08005550"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}